Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040175 | SCV000063866 | likely benign | not specified | 2012-05-24 | criteria provided, single submitter | clinical testing | 30805+9G>T in intron 146 of TTN: This variant is not expected to have clinical s ignificance because it is not located within the splice consensus sequence. 30 805+9G>T in intron 146 of TTN (allele frequency = n/a) |
Gene |
RCV000040175 | SCV000531773 | likely benign | not specified | 2017-07-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000730362 | SCV000858092 | uncertain significance | not provided | 2017-11-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001399669 | SCV001601460 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000040175 | SCV001924947 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000730362 | SCV001963605 | likely benign | not provided | no assertion criteria provided | clinical testing |